Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
OxyContin maker Purdue Pharma's settlement, by the numbers
OxyContin maker Purdue Pharma is set to dissolve and be replaced with a new company operating in the public interest under the settlement of thousands of lawsuits that goes into effect Friday. It's among the largest in a series of settlements over…
Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026
Company announcement – No. 12 / 2026 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no.
Leo Pharma Is Said to Add More Banks to Copenhagen IPO Lineup
Leo Pharma AS has picked more banks to help it prepare for a possible initial public offering in Copenhagen, according to people familiar with the matter. The century-old drugmaker has brought in Goldman Sachs Group Inc., Jefferies Financial Group…
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
Tokyo, Japan and Cambridge, UK, 1 May 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31…
The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting
The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting Camilla Sylvest will bring deep commercial expertise to the Board at a critical stage, as Zealand Pharma…
Colorado to get $75 million from opioid settlement with Purdue Pharma
A $7.4 billion settlement reached with the pharmaceutical company Purdue Pharma and the Sackler family — its owners — is now legally effective a decade after attorneys general from multiple states launched an investigation and seven…
Arkansas to receive over $44M following multi-billion-dollar settlement with Purdue Pharma
LITTLE ROCK, Ark. — Arkansas is now set to receive a substantial sum of money following a multi-billion-dollar settlement that was reached with Purdue Pharma and its owners. After nearly a decade of work by attorneys general from Arkansas…
Review of pharma, medical devices sector's supply chain resilience on cards
India is undertaking an assessment of the industrial supply chain resilience and manufacturing capabilities of the pharmaceutical and medical devices sector. It is an important exercise and the Supply Chain Division of the Department of Commerce is…
Opioid maker Purdue Pharma shuts down as part of legal settlement with NY and other states
Purdue Pharma officially ended operations Friday, a year after the Sackler family reached a $7.4 billion settlement with a coalition of state attorneys general, including New York's, for the company's role in fueling the opioid crisis.
Aurobindo Pharma arm CuraTeQ gets Health Canada NOC for Bevacizumab biosimilar
Aurobindo Pharma subsidiary CuraTeQ Biologics has received Notice of Compliance (NOC) from Health Canada's Biologics and Radiopharmaceutical Drugs Directorate (BRDD) for Bevqolva, its bevacizumab biosimilar. A humanised monoclonal antibody…
$7.4 billion Purdue Pharma, Sackler family opioid settlement now in effect
This illustration image shows tablets of opioid painkiller Oxycodone delivered on medical prescription taken on September 18, 2019 in Washington,DC. - Millions of Americans sank into addiction after using potent opioid painkillers that the…
Attorney General Bonta Announces $7.4 Billion Purdue Pharma and Sackler Family Opioid Settlement Now in Effect
Press releases are posted on Independent.com as a free community service. OAKLAND — California Attorney General Rob Bonta today announced that a $7.4 billion settlement previously reached with Purdue Pharma and its owners, the Sackler…
Vanguard Group Inc. Increases Stake in BridgeBio Pharma, Inc. $BBIO
Vanguard Group Inc. grew its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 0.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,862,691 shares of the…
$7.4B Purdue opioid settlement goes into effect after years of litigation
NEWARK, N.J. — A $7.4 billion settlement with Purdue Pharma and the Sackler family over their role in the nationwide opioid crisis now legally in effect. The OxyContin maker will be dissolved and replaced by a company focused on the public…
Curaleaf Announces Appointment of Torsten Greif to Board of Directors
STAMFORD, Conn., May 1, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ('Curaleaf' or the 'Company'), a leading international provider of consumer cannabis products, today announced the appointment of Torsten Greif to the Curaleaf…
Receive a Daily briefing on Pharma Industry News
Get Started